PMH42 COST-EFFECTIVENESS ANALYSIS OF OLANZAPINE LONG-ACTING INJECTION COMPARED WITH RISPERIDONE LONG-ACTING INJECTION IN THE TREATMENT OF SCHIZOPHRENIA IN NORWAY
Abstract
Authors
SM Carroll N Jemiai B Suter P ODonohoe U Skjoldborg J Moller OK Kleivenes D Novick